Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of July 26 - August 1, 2021.
Alerts this week cover papers from New England, Nature Cancer and Lancet Oncology.
Dr Morgan also highlights the FDA approval of pembrolizumab for high-risk early stage triple negative breast cancer.
You can watch Dr Morgan's previous roundup here.
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer